Skip to main content

Liver Anatomy and Function

  • Chapter
  • First Online:
Radiation Therapy for Liver Tumors

Abstract

The liver’s primary physiologic functions include: lipid, carbohydrate, and protein metabolism; coagulation factor production; albumin production; detoxification of xenobiotics; storage of vitamins and glycogen; and bile processing and secretion. Disease processes affecting these functions are usually directed at hepatocytes, blood vessels, or bile ducts within the liver, and can produce a wide spectrum of liver disease. There are three basic morphologic appearances of the failed liver: massive hepatic necrosis, chronic liver disease resulting in cirrhosis, and hepatic dysfunction without overt necrosis. Of these, cirrhosis is the most common cause of liver related deaths and is the twelfth leading cause of death in the United States. The primary pathophysiologic influence behind the vast majority of decompensating events—such as gastrointestinal bleeding—in cirrhotic patients is portal hypertension, i.e. the increased resistance to portal blood flow that creates an increased gradient of pressure between the portal vein and the inferior vena cava. When the portal pressure increases beyond 12 mm Hg, patients are prone to develop ascites, varices, and hepatic encephalopathy. Transjugular intrahepatic portosystemic shunts (TIPS) alleviate portal hypertension, and therefore some of its complications, by lowering the portal pressure below the threshold of 12 mm Hg. Still, despite advances in medical care, many patients with cirrhosis require an evaluation for liver transplantation. The Child-Turcotte-Pugh score has been a mainstay for assessing severity of cirrhosis. Additionally, the Model for End-Stage Liver Disease (MELD) score—a value ranging from 6 to 40, derived from a patient’s serum creatinine, total bilirubin, and international normalized ratio (INR)—is used to predict mortality in patients with end stage liver disease and has been used for liver transplant allocation system in the United States. Since 2016, serum sodium was formally added to the MELD equation, based on data that hyponatremia is predictive of mortality in cirrhotic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

TIPS:

Transjugular Intrahepatic Portosystemic Shunt

MELD:

Model for End-Stage Liver Disease

INR:

International Normalized Ratio

TACE:

Transarterial chemoembolization

AST:

Aspartate aminotransferase

ALT:

Alanine aminotransferase

CTP:

Child-Turcotte-Pugh

OPTN:

Organ Procurement Transplantation Network

UNOS:

United Network for Organ Sharing

References

  1. Theise ND. Liver and gallbladder. In: Kumar V, Abbas AK, Aster JC, editors. Robbins and Cotran pathologic basis of disease. Philadelphia: Elsevier Saunders; 2015. p. 821–81.

    Google Scholar 

  2. Crawford JM, Burt AD. Anatomy, pathophysiology, and basic mechanisms of disease. In: Burt AD, Portmann BC, Ferrell LD, editors. MacSween’s pathology of the liver. Edinburgh: Churchill Livingstone Elsevier; 2012. p. 1–77.

    Google Scholar 

  3. U.S. Department of Health & Human Services. Organ Procurement and Transplantation Network. http://optn.transplant.hrsa.gov. Accessed 13 May 2014.

  4. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342(17):1266–71.

    Article  CAS  PubMed  Google Scholar 

  5. Dutta A, Saha C, Johnson CS, Chalasani N. Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study. Hepatology. 2009;50(6):1957–62.

    Article  CAS  PubMed  Google Scholar 

  6. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217–31.

    Article  PubMed  Google Scholar 

  7. D’Amico G, Pasta L, Morabito A, D’Amico M, Caltagirone M, Malizia G, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39(10):1180–93.

    Article  PubMed  Google Scholar 

  8. Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int: Official J Int Assoc Study Liver. 2012;32(9):1407–14.

    Article  CAS  Google Scholar 

  9. Gines P, Fernandez-Esparrach G, Arroyo V. Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment. Baillieres Clin Gastroenterol. 1997;11(2):365–85.

    Article  CAS  PubMed  Google Scholar 

  10. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol. 1999;30(5):890–5.

    Article  CAS  PubMed  Google Scholar 

  11. Boyer TD, Haskal ZJ. American Association for the Study of Liver D. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. Hepatology. 2010;51(1):306.

    Article  PubMed  Google Scholar 

  12. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–6.

    Article  PubMed  Google Scholar 

  13. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol. 2004;40(6):897–903.

    Article  PubMed  Google Scholar 

  14. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–71.

    Article  CAS  PubMed  Google Scholar 

  15. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–70.

    Article  CAS  PubMed  Google Scholar 

  16. Biggins SW, Bambha K. MELD-based liver allocation: who is underserved? Semin Liver Dis. 2006;26(3):211–20.

    Article  PubMed  Google Scholar 

  17. Kalra A, Wedd JP, Biggins SW. Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions, and more. Curr Opin Organ Transplant. 2016;21(2):120–6.

    Article  PubMed  Google Scholar 

  18. Smith JM, Biggins SW, Haselby DG, Kim WR, Wedd J, Lamb K, et al. Kidney, pancreas and liver allocation and distribution in the United States. Am J Transpl: Official J Am Soc Transpl Am Soc Transplant Surg. 2012;12(12):3191–212.

    Article  CAS  Google Scholar 

  19. Biggins SW. Beyond the numbers: rational and ethical application of outcome models for organ allocation in liver transplantation. Liver Transpl: Official Publ Am Assoc Study Liver Dis Int Liver Transpl Soc. 2007;13(8):1080–3.

    Article  Google Scholar 

  20. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005;41(1):32–9.

    Article  CAS  PubMed  Google Scholar 

  21. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130(6):1652–60.

    Article  PubMed  Google Scholar 

  22. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359(10):1018–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Biggins SW. Use of serum sodium for liver transplant graft allocation: a decade in the making, now is it ready for primetime? Liver Transpl: Official Publ Am Assoc Study Liver Dis Int Liver Transpl Soc. 2015;21(3):279–81.

    Article  Google Scholar 

  24. Garwood ER, Fidelman N, Hoch SE, Kerlan RK Jr, Yao FY. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction. Liver Transpl: Official Publ Am Assoc Study Liver Dis Int Liver Transpl Soc. 2013;19(2):164–73.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Scott W. Biggins MD, MAS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Kaplan, J.B., Kalra, A., Biggins, S.W. (2017). Liver Anatomy and Function. In: Meyer, J., Schefter, T. (eds) Radiation Therapy for Liver Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-54531-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-54531-8_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-54530-1

  • Online ISBN: 978-3-319-54531-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics